# Alamar

- Location (FDA's records): Sacramento, CA
- FDA decisions: 7 (1991–1991): 7 510(k) clearances
- Product codes: JWY (7)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K911391: Antimicrobial Suscept. Test Panel (Ceftizoxime) (May 8, 1991)
- K911390: Antimicrobial Suscept. Test Panel (Trimethoprim) (May 8, 1991)
- K911389: Antimicrobial Susceptibility Test Panel (Imipenem) (May 8, 1991)
- K911392: Antimicrobial Susceptibility Test Panel (Cefotetan (May 8, 1991)
- K910484: Antimicrobial Susceptibility Test Panel (Mar 11, 1991)
- K910345: Antimicrobial Cefoperazone (Feb 25, 1991)
- K910346: Antimicrobial Ceftriaxone (Feb 25, 1991)

Source page: https://510kreport.com/company/alamar